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Abstract
As a response to high osmolality, many microorganisms synthesize various types of compatible solutes. These organic
osmolytes aid in offsetting the detrimental effects of low water activity on cell physiology. One of these compatible solutes
is ectoine. A sub-group of the ectoine producer’s enzymatically convert this tetrahydropyrimidine into a hydroxylated
derivative, 5-hydroxyectoine. This compound also functions as an effective osmostress protectant and compatible solute
but it possesses properties that differ in several aspects from those of ectoine. The enzyme responsible for ectoine
hydroxylation (EctD) is a member of the non-heme iron(II)-containing and 2-oxoglutarate-dependent dioxygenases (EC
1.14.11). These enzymes couple the decarboxylation of 2-oxoglutarate with the formation of a high-energy ferryl-oxo
intermediate to catalyze the oxidation of the bound organic substrate. We report here the crystal structure of the ectoine
hydroxylase EctD from the moderate halophile Virgibacillus salexigens in complex with Fe
3+ at a resolution of 1.85 A ˚. Like
other non-heme iron(II) and 2-oxoglutarate dependent dioxygenases, the core of the EctD structure consists of a double-
stranded b-helix forming the main portion of the active-site of the enzyme. The positioning of the iron ligand in the active-
site of EctD is mediated by an evolutionarily conserved 2-His-1-carboxylate iron-binding motif. The side chains of the three
residues forming this iron-binding site protrude into a deep cavity in the EctD structure that also harbours the 2-
oxoglutarate co-substrate-binding site. Database searches revealed a widespread occurrence of EctD-type proteins in
members of the Bacteria but only in a single representative of the Archaea, the marine crenarchaeon Nitrosopumilus
maritimus. The EctD crystal structure reported here can serve as a template to guide further biochemical and structural
studies of this biotechnologically interesting enzyme family.
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Introduction
Environmentally imposed osmotic gradients instigate large
water fluxes across the semi-permeable cytoplasmic membrane
of microorganisms. As a result, the bacterial cell is threatened by
rupture at low osmolality due an undue rise in turgor [1] or by
dehydration and a collapse of turgor at high osmolality [2,3]. At
high external osmolality, many microorganisms accumulate a
selected group of organic osmolytes, the so-called compatible
solutes, to actively counteract the detrimental effects of water
efflux on cell physiology [4]. These compounds are fully
congruous with metabolism and other cellular functions and
can thus be amassed to exceedingly high intracellular levels. As
a direct consequence of compatible solute accumulation, the
osmotic potential of their cytoplasm is raised. This allows
retention of water by the microbial cell, promotes water re-
entry, stabilizes turgor and aids the cell in its physiological
adjustment to the prevailing osmotic conditions in its
environment [2–4].
Ectoine [(S)-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxyl-
ic acid] (Figure 1) is one of the most widely synthesized compatible
solutes by microorganisms [4–6]. In all ectoine-producing bacteria
analyzed so far, ectoine biosynthesis is strongly enhanced under
high-osmolality growth conditions. This is largely a consequence
of the osmotic induction of the expression of the ectoine
biosynthetic genes, ectABC [5,7–14]. Three enzymes mediate
ectoine biosynthesis from L-aspartate-b-semialdehyde, a central
intermediate in amino acid metabolism [15], through the
sequential catalytic actions of the L-2,4-diaminobutyrate transam-
inase (EctB), the L-2,4-diaminobutyrate acetyltransferase (EctA)
and the ectoine synthase (EctC) [4–6,11]. A subset of microbial
ectoine producers also synthesize a hydroxylated derivative of
ectoine, 5-hydroxyectoine [(S,S)-2-methyl-5-hydroxy-1,4,5,6-tetra-
hydropyrimidine-4-carboxylic acid] (Figure 1) [5,16,17]. Synthesis
of 5-hydroxyectoine depends on the prior production of ectoine. It
should be noted in this context that a microbial cell stressed by
high salinity cannot gain any advantage in adjusting to high
osmolality by enzymatically converting de novo synthesized ectoine
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10647into 5-hydroxyectoine. This suggests that the physiological
function of 5-hydroxyectoine production is not primarily a
response to osmotic challenges, but instead is directed towards
other types of environmental and cellular stress conditions. Indeed,
formation of 5-hydroxyectoine is required in Chromohalobacter
salexigens to attain full thermo-stress resistance [16]; in addition,
Streptomyces coelicolor cells challenged by high temperature produce
5-hyroxyectoine in preference to ectoine [7]. Furthermore, the
formation of 5-hydroxyectoine is stimulated when either S. coelicolor
[7], V. salexigens [5] or Marinococcus M52 [18] cultures become
stationary, a growth phase that posesses considerable challenges
for microbial cells.
Ectoine and 5-hydroxyectoine are closely related chemically
(Figure 1) and both function as effective compatible solutes [18–
22]. Their cellular accumulation, either via de novo synthesis or
transport processes [7,23,24], can confer protection against salt
stress, temperature stress and dehydration [7,9,23–25]. However,
the influence of ectoine and 5-hydroxyectoine on biological
macromolecules and cells can differ in several aspects. For
instance, ectoine decreases, whereas 5-hydroxyectoine increases
the melting temperature of DNA [26,27]. Furthermore, the
protein-stabilizing capacity of these two tetrahydropyrimidines can
substantially vary when tested in vitro with the same model proteins
[19,28].
Ectoine and 5-hydroxyectoine have attracted considerable
biotechnological attention and are currently produced on an
industrial scale by high-density fermentation of salt-tolerant
bacteria [29]. They have found versatile uses as in vitro protein
stabilizers, as PCR enhancers, as in vivo protein folding catalysts, as
whole cell stabilizers and, foremost in skin care products for
cosmetics [29,30]. Medical applications for both ectoine and 5-
hydroxyectoine are currently considered [20,31,32]. Furthermore,
the ectoine biosynthetic genes have been used for the genetic
engineering of tobacco plants resistant to salt stress [33].
The ability to form 5-hydroxyectoine is dependent on an
evolutionarily conserved ectoine hydroxylase, EctD [5,7,16,17].
The biochemical characterization of this hydroxylase from the
moderate halophile Virgibacillus salexigens (formerly Salibacillus
salexigens) [5] and from the soil bacterium S. coelicolor [7] has
revealed that the EctD enzyme is a member of the non-heme
iron(II)-containing and 2-oxoglutarate-dependent dioxygenases
superfamily (EC 1.14.11). Members of this enzyme family are
widespread in both Pro- and Eukarya and catalyze a broad
spectrum of oxidative reactions including cyclizations, ring
fragmentations, C-C bond cleavages, epimerizations, desatura-
tions, halogenations, and hydroxylations of widely varying organic
compounds [34–36]. This group of enzymes typically couples the
decarboxylation of 2-oxoglutarate with the formation of a high-
energy ferryl-oxo intermediate that acts as a hydrogen-abstracting
species. The formed Fe(IV)=O species is directly responsible for
the oxidation of the organic substrate bound by the enzyme. Non-
heme iron(II)-containing and 2-oxoglutarate-dependent dioxy-
genases probably constitute the most versatile group of all
oxidizing biological catalysts [37].
Structural studies of these dioxygenases revealed a common
protein fold as well as a highly conserved iron-binding motif, the
so-called 2-His-1-carboxylate facial triad [34–36]. The amino acid
sequence of EctD possesses this type of iron-binding motif
[5,7,16,17] and EctD catalyzes an enzymatic reaction [5,7] that
is common in non-heme iron(II)-containing and 2-oxoglutarate-
dependent dioxygenases [38]. In this reaction, the O2-dependent
hydroxylation of the substrate ectoine is accompanied by the
oxidative decarboxylation of 2-oxoglutarate to form succinate and
CO2 (Figure 1).
EctD-type proteins are found widely in members of the domain
of Bacteria [5,16], but a crystal structure of an ectoine hydroxylase
has not yet been reported. Building on the biochemical
characterization of the ectoine hydroxylase from V. salexigens [5],
we now report the crystal structure of EctD in complex with Fe
3+
at a resolution of 1.85 A ˚. The EctD crystal structure reveals the
details of the iron-binding site and also suggests an architectural
arrangement for three residues that likely bind and position the co-
substrate 2-oxoglutarate with the active site of the EctD enzyme.
Our structural data identify the ectoine hydroxylase as a member
of the sub-group of PhyH-like enzymes [39,40] within the non-
heme iron(II)-containing and 2-oxoglutarate-dependent depen-
dent dioxygenases superfamily.
Results and Discussion
Structure determination of EctD
The X-ray structure of the EctD protein from V. salexigens was
determined by multi-wavelength anomalous diffraction (MAD)
using selenium in selenomethionine as the anomalous scatterer.
Crystals of both selenomethionyl-EctD and natural EctD typically
showed a mosaicity of more than 2u so that among many obtained
crystals only a very few proved to be suitable for X-ray analysis.
Since the lowest mosaicity and best resolution was attained from a
selenomethionyl-EctD crystal, we used a dataset from this crystal
recorded at a remote wavelength for refinement. The crystal
structure of EctD was refined at a resolution of 1.85 A ˚ with an
Rcryst of 19.3% and an Rfree of 22.8% (for crystallographic details
see Tables S1 and S2). The crystal structure revealed one protein
monomer per asymmetric unit, which represents the functional
unity of the V. salexigens EctD enzyme as previously shown by size
exclusion chromatography [5]. One molecule of the V. salexigens
EctD protein originally consists of 300 amino acids, resulting in a
molecular mass of 34.4 kDa. The ectoine hydroxylase from V.
salexigens used for crystallization was produced in Escherichia coli by
recombinant DNA techniques and modified with a carboxy-
terminal Strep-affinity tag for protein purification. However, the
Strep-tag peptide as well as the carboxy-terminal four amino-acid
residues (297 to 300) of the authentic EctD protein were
disordered in the crystal and thus excluded from the model of
Figure 1. Enzymatic reaction scheme for the EctD-mediated
hydroxylation of ectoine.
doi:10.1371/journal.pone.0010647.g001
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from amino acid residues 195 to 211 was omitted from the model
since no electron density could be assigned to this segment of the
EctD protein. The amino-terminal (seleno-) methionine of EctD,
although ill-defined in the electron density, was included in the
model since the position of its selenium atom was unambiguously
identified during the MAD experiment. It represents residue 1 in
our numbering system. In addition to 197 water molecules, the
refined structure contains one Fe
3+ ion as well as four non-
specifically bound sulfates and two glycerol molecules that
originate from the reservoir and cryo-solutions, respectively.
Overall three-dimensional architecture of EctD
As commonly observed for members of the non-heme iron(II)-
containing and 2-oxoglutarate-dependent dioxygenases, the EctD
structure consists of a double-stranded b-helix (DSBH) core
decorated with and stabilized by a number of a-helices (Figure 2A).
The DSBH, also referred to in literature as the jelly-roll fold, is
formed by two four-stranded anti-parallel b-sheets which are
arranged in the form of a b-sandwich. It is composed of strands b-
5, b-6, b-7, b-8, b-10, b-11, b-12, and b-13 (Figure 2A), hereafter
referred to as b-I to b-VIII for consistency in nomenclature. As in
other non-heme iron(II)-containing and 2-oxoglutarate-dependent
dioxygenases, b-II, b-VII, b-IV, and b-V form the distorted minor
sheet, which is so called because of its shorter strand lengths, while
the major sheet is formed by b-I, b-VIII, b-III, and b-VI. In EctD,
the major sheet is extended on both sides by the anti-parallel
strands b-2, b-3, and b-4 (Figure 2A).
A structural alignment search using the DALI server [41] and the
EctD structure as search template revealed that most non-heme
iron(II)-containing and 2-oxoglutarate-dependent dioxygenases and
related enzymes are structurally similar to EctD (‘‘Z-scores’’ » 2).
Two of these showed a particularly high structural similarity to
EctD: the human phytanoyl-CoA 2-hydroxylase PhyH [40] and the
halogenase SyrB2 from Pseudomonas syringae [42] (Z-scores of 22.5 or
18.2, respectively). Remarkably, the specific substrates of these two
enzymes are covalently tethered as thioesters to a phosphopan-
tetheinyl group of CoA (in case of PhyH) or of a peptidyl carrier
protein domain (in case of SyrB2), whereas the substrate of EctD is
freely diffusible. In the ‘‘Structural Classification of Proteins’’
(SCOP) database [39], PhyH and SyrB2 are combined into the
family of PhyH-like enzymes. Our data on the crystal structure of
EctD now group this ectoine hydroxylases into the PhyH family as
well. In the crystal structures of EctD, PhyH, and SyrB2, an
extended region containing four a-helices packed against the major
sheet of the DSBH motif precede the amino terminus of the DSBH.
This amino-terminal section is highly reminiscent of that present in
enzymes of the isopenicillin-N-synthase IPNS/deacetoxycephalos-
porin C synthase (DAOCS)-like family [43,44]. However, in the
members of this family, the helices a-3 and a-4 present in EctD,
PhyH, and SyrB2 are fused to one long helix (Figure 3). The major
difference between the enzymes of the IPNS/DAOCS family and
that of the PhyH family is the way in which b-strands IV and V of
the DSBH structural motif are linked with each other. In the IPNS/
DAOCS family these strands are connected by a short loop in the
structures of the EctD, PhyH, and SyrB2 proteins, but this loop is
extended and most likely forms part of the ligand-binding pocket in
all three enzymes [40,42].
When the crystal structures of EctD, PhyH, and SyrB2 are
compared, the largest structural differences in these three enzymes
Figure 2. Ribbon and surface representation of the EctD ectoine hydroxylase. (A) The successive segments of the double-stranded b-helix
(DSBH) are coloured according to the scheme of Branden and Tooze [75]. The Fe
3+ ion bound by EctD is shown as a blue sphere. A dashed line
indicates a disordered loop region connecting the DSBH b-strands IV and V. (B) The surface of the EctD protein is represented and the side-chains of
the iron-coordinating residues His-146, Asp-148 and Asp-248 are shown as sticks. The iron ion bound by the crystallized EctD protein is shown as a
blue sphere.
doi:10.1371/journal.pone.0010647.g002
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PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10647Figure 3. Topology diagrams of PhyH-family enzymes PhyH, SyrB2 and EctD and of the DAOCS enzyme. (A) PhyH (PDB code: 2A1X), (B)
SyrB2 (PDB code: 2FCU) and (C) EctD (PDB code: 3EMR). (D) Topology diagram of DAOCS (PDB code: 1DCS), a representative of the family of the IPNS/
DAOCS-like enzymes. Arrows represent b-strands, while a-helices are shown as cylinders. 310-helices are also shown as cylinders, but not numbered.
The b-strands forming the DSBH-motif are coloured according to the scheme of Branden and Tooze [75]. In the diagrams of EctD and PhyH, the
disordered putative ‘‘lid’’ region within the segment connecting DSBH b-strands IV and V is shown by dashed lines. For the sake of clarity and
comparability, DSBH b-strand II is included in the topology diagram of PhyH, although this strand is largely disordered and invisible in the
corresponding crystal structure [40].
doi:10.1371/journal.pone.0010647.g003
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differences in the region connecting helices a-2 and a-3
(Figure 3). In EctD and PhyH, this region harbours two anti-
parallel b-strands that extend the major DSBH sheet by adjoining
the carboxy-terminal part of b-strand I. Such anti-parallel b-
strands are missing in the corresponding region of SyrB2.
Compared to PhyH and SyrB2, the amino terminus of EctD is
significantly extended. It contains a b-strand (b-1) that is aligned
anti-parallel to b-strand 9 located in the segment connecting
DSBH b-strands IV and V. In contrast, both PhyH and SyrB2 are,
in comparison to EctD, prolonged at their carboxy termini, which
in both enzymes contain a b-strand adjoining anti-parallel to the
amino-terminal part of DSBH b-strand I (Figure 3).
The Fe
2+ binding site in EctD
The enzymatic function of the non-heme iron(II)-containing
and 2-oxoglutarate-dependent dioxygenases depends on a highly
reactive iron species [35–38]. Typically for this enzyme super-
family, the two sheets of the DSBH form the main portion of a
deep cavity containing the catalytic Fe
2+, the binding site for the
co-substrate 2-oxoglutarate, and at least part of the substrate-
binding site. In most enzymes of this group, the Fe
2+ ion is
coordinated by two histidine imidazoles and the carboxylate of an
aspartate or, more rarely, a glutamate residue which together form
the so-called 2-His-1-carboxylate facial triad. One of the histidines
and the aspartate/glutamate residue are arranged in a conserved
His-X-Asp/Glu sequence motif [34–38]. Although no iron salt had
been added to the buffer used for crystallisation of the EctD
protein, the experimental electron density clearly indicated a
bound metal ion in the active centre of the enzyme that was
subsequently refined as an iron ion. It has been previously
reported, that the EctD enzyme from V. salexigens when
heterologously produced in E. coli contains a ferric ion [5] and
this iron molecule was apparently maintained in the crystallization
process of the EctD protein. The metal ion is coordinated by the
functional groups of His-146, Asp-148 and His-248 of the EctD
protein and three water molecules in an almost perfect octahedral
geometry (Figure 4). The temperature- or B-factor of an atom
within a structural model is a measure of the freedom of
movement of this atom. In the structure of EctD, the B-factor of
the bound metal ion was refined to 23.9 A ˚ 2 which is below the
average B-factor of the protein main chain atoms (26.3 A ˚ 2; Table
S2) indicating that the Fe
3+ is rigidly bound to the protein and
excellently defined in the electron density map. The B-factors of
the water ligands are 31.3 A ˚ 2, 36.0 A ˚ 2, and 47.9 A ˚ 2 (average B-
factor of all water molecules: 37.2 A ˚ 2; Table S2). The three
residues (His-146, Asp-148, His-248) forming this iron-binding site
protrude into a deep cavity in the EctD structure that houses the
active site of the enzyme (Figure 2B).
Residues likely to be involved in 2-oxoglutarate binding
by EctD
In all non-heme iron(II)-containing and 2-oxoglutarate-depen-
dent dioxygenases, the co-substrate 2-oxoglutarate is bound at the
base of the binding cavity of the enzyme and participates in the
coordination of the Fe
2+ ion via its 1-carboxylate and 2-oxo moiety
in a bidentate manner. The 5-carboxylate is typically stabilized by
a salt bridge formed with the basic group of an arginine or lysine
side chain and by at least one hydrogen bond formed to a hydroxyl
group of the protein [34]. With few exceptions, the basic residue
salt-bridging the 5-carboxylate of 2-oxoglutarate protrudes from
the amino-terminus of the DSBH b-strand VIII. An arginine
residue is invariantly present in 71 EctD-type proteins compiled by
us through database searches (Figure S1) and corresponds to Arg-
259 in the V. salexigens EctD enzyme (Figure 5D). In members of
the IPNS/DAOCS family and a few other non-heme iron(II)-
containing and 2-oxoglutarate-dependent dioxygenases, the basic
residue and hydroxyl group stabilizing the 5-carboxylate of 2-
oxoglutarate stem from an Arg–X–Ser sequence motif [34]. This
motif is not present in EctD, as residue 261 of the S. salexigens
enzyme is a non-conserved asparagine residue (Figure S1).
Despite intensive efforts, we were not able to grow EctD crystals
in the presence of 2-oxoglutarate. We therefore can only glean
information about those residues that might be involved in 2-
oxoglutarate binding by comparing the EctD ligand-binding
pocket with crystal structures of non-heme iron(II)-containing
and 2-oxoglutarate-dependent dioxygenases that actually contain
this co-factor. In the PhyH enzyme that is structurally most closely
related to EctD, the 2-oxoglutarate-interacting hydroxyl group is
provided by Ser-266, positioned two residues away from the Fe
2+-
chelating His-264 residue on DSBH b-strand VII [40] (Figure 5A).
The corresponding residue Ser-250 is strictly conserved in 71
EctD-type proteins (Figure S1) and as in PhyH, it is positioned two
residues after the invariant Fe
2+-chelating His-248 (Figure 5D and
Figure S1). Furthermore, in the EctD-related SyrB2 crystal
structure, two residues after His-235, there is a serine residue
(Ser-237) at the corresponding position as well. However, in the
SyrB2 halogenase, the hydroxyl group of Ser-237 is not directly
involved in 2-oxoglutarate binding. Instead, it forms hydrogen
bonds with the hydroxyl group of Thr-113, thereby establishing an
additional hydrogen bond to the 5-carboxylate of 2-oxoglutarate
(Figure 5B) [42].
Notably, in the recently determined structure of the pentaleno-
lactone biosynthesis enzyme PtlH from Streptomyces avermitilis,a
serine is also found two residues after the Fe
2+-chelating His-226
[45]. As in the PhyH structure, Ser-228 of the PtlH enzyme
directly hydrogen-bonds the 5-carboxylate of 2-oxoglutarate
(Figure 5C). PtlH shows high structural similarity to EctD (DALI
Z-score of 16.3) and, according to its overall topology, most likely
is a member of the structural family of PhyH-like enzymes as well.
With the exception of a prolyl-4-hydroxylase from Chlamydomonas
reinhardtii [46], none of the remaining non-heme iron(II)-contain-
ing and 2-oxoglutarate-dependent dioxygenases with known
structure contains a serine at the corresponding position.
Therefore, the His-X-Ser motif, with the histidine being the distal
Fe
2+-chelating residue and the serine providing an alcohol directly
or indirectly stabilizing the 5-carboxylate of the co-substrate 2-
Figure 4. Stereo view of the EctD Fe
2+-binding site. A co-purified
Fe
3+ (orange sphere) is coordinated by the side chain functional groups
of His-146, Asp-148 and Asp-248 of EctD and by three water molecules
(shown as red spheres). The |Fobs|–| Fcalc| difference electron density
(blue mesh) is shown at a sigma level of 3.0 after refinement of the
structural model excluding both the Fe
3+ and its three water ligands.
doi:10.1371/journal.pone.0010647.g004
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PhyH-like enzymes.
We noted that the phenyl ring of Phe-143 on DSBH b-strand II
protrudes into the presumed binding pocket of the EctD enzyme,
where it makes no interactions with any further EctD residue
(Figure 5D). Accordingly, the aromatic ring system of this amino
acid is freely rotatable and, therefore, ill defined in the electron
density. Nevertheless, its positioning suggests that it is able to
make, upon binding of 2-oxoglutarate, a stacking interaction with
the co-substrate via its aromatic side-chain. Consistent with the
proposed role of Phe-143 in 2-oxoglutarate binding, replacement
of this amino acid by either Ala, Trp or Tyr residues resulted in
enzymatically inactive EctD derivatives (M. Pittelkow and E.
Bremer; unpublished data). A phenylalanine is not found at an
equivalent position in any other non-heme iron(II)-containing and
2-oxoglutarate-dependent dioxygenase of known structure with
the exception of the human histone demethylase JMJD2A [47,48].
Indeed, the corresponding Phe-185 residue in JMJD2A makes via
its aromatic side chain a Van-der-Waals contact to the bound 2-
oxoglutarate or its analogue N-oxalylglycine. The histone
demethylase JMJD2A shows, however, only moderate overall
structural similarity to EctD (DALI Z-score of 5.9).
It should be noted in the context of the discussion of the
architecture of the 2-oxoglutarate-binding site, that the actual
orientation of the guanidino function of Arg-259, as represented in
the EctD crystal structure, is not in a position that would allow
Arg-259 to form a salt bridge to 2-oxoglutarate (Figure 5D). This
can readily be rationalized in view of the absent 2-oxoglutarate in
Figure 5. Binding of 2-oxoglutarate by PhyH-like enzymes. (A) PhyH, (B) SyrB2 and (C) PtlH (PDB code: 2RDN) and (D) EctD. The Fe
2+ ion is
shown as a blue sphere, water molecules are shown as red spheres. Side chains of residues involved in 2-oxoglutarate binding or in Fe
2+ coordination
are represented as sticks. Secondary structure elements are indicated as ribbons. The positioning of Phe-143 residue in the EctD structure makes in all
likelihood an interaction via its aromatic side chain with 2-oxoglutarate. However, the conformation of the Phe-143 side chain shown in this figure
must be regarded as tentative as it is poorly defined in the electron density map (in contrast to the Phe-143 main chain atoms). In addition, the actual
orientation of the Arg-259 side chain in the EctD crystal structure is not in a position enabling its guanidino function to salt bridge the 5-carboxylate
of a bound 2-oxoglutarate. However, a position allowing this interaction can easily be achieved through torsion around rotatable single bonds within
the side chain of this Arg residue. It also should be noted that the DSBH b-strand II of PhyH is largely disordered in the crystal structure of this protein.
In the EctD structure, the corresponding b-strand also strongly deviates from ideal b-strand geometry.
doi:10.1371/journal.pone.0010647.g005
Ectoine Hydroxylase
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flexibility in the positioning of the Arg-259 side-chain. However,
an Arg-259 position that allows interaction with 2-oxoglutarate
can easily be achieved through torsion around rotatable single
bonds within the side chain of this Arg residue.
A flexible loop in EctD that might be involved in
structuring the ligand-binding pocket
The section of the EctD polypeptide chain extending from
residues Gly-195 to Leu-211 is disordered in the crystal and
consequently not visible in the electron density map. This putative
loop region is part of an expanded section of the polypeptide chain
connecting DSBH b-strands IV and V of EctD (Figure 2A and
Figure 3D). Val-194 and the strictly conserved Gly-212 (Figure
S1), two residues that are positioned close to the border of the
presumable ligand-binding cavity, flank the disordered loop in the
EctD crystal structure. Such an arrangement suggests that this
loop might constitute a kind of a flexible ‘‘lid’’ which becomes
ordered upon substrate binding.
Notably, in the crystal structure of the EctD-related PhyH
protein, the region between residues 223 and 233, which largely
corresponds to the disordered loop in EctD, is disordered as well
[40]. The PhyH crystal structure was determined in complex with
the ligands Fe
2+ and 2-oxoglutarate but without the PhyH-specific
substrate, phytanoyl-CoA. McDonough et al. [40] discussed the
possibility that the flexible loop present in PhyH might serve to
enclose the active site after binding of all reactants by the PhyH
enzyme. In the recently determined crystal structure of the non-
heme iron(II)-containing and 2-oxoglutarate-dependent aspara-
gine hydroxylase AsnO from S. coelicolor, such a lid has been clearly
identified [49]. A loop comprising residues 208 to 223 of AsnO is
partially disordered in the crystal structure of the apo-form of
AsnO but upon ligand-binding, a pronounced structural rear-
rangement occurs that allows the crystallographic resolution of this
flexible segment in AsnO [49]. Strikingly, this mobile lid-structure
of AsnO corresponds to the unstructured regions in both the EctD
and PhyH crystal structures. As discussed for PhyH [40], Strieker
et al. [49] also suggest that the flexible loop of AsnO serves to shield
the reactants from the surrounding solvent during enzyme
catalysis. Furthermore, in the AsnO-related VioC L-arginine
oxygenase involved in the biosynthesis of the tuberactinomycin
antibiotic viomycin from Streptomyces vinaceus, a structurally flexible
lid-like region that shields the active site upon substrate binding
has been identified as well [50]. In view of the available data on
the lid-regions in the PhyH, AsnO, and VioC crystal structures, it
is tempting to speculate, that a similar ‘‘lid-movement’’ mecha-
nism might also operate during the catalytic cycle of the EctD-
mediated hydroxylation of ectoine.
A structural perspective on the signature sequence motif
of EctD–type ectoine hydroxylases
Based on an alignment of a restricted number of EctD-related
proteins, Bursy et al. [5] have previously noted a conserved
segment of nine amino acid residues (-W
145HSDFETWH
153-) and
suggested that it might serve as a signature-sequence motif for bona
fide ectoine hydroxylases. Our updated data base searches for
proteins related to the V. salexigens ectoine hydroxylase extended
this signature sequence motif to F
143-X-WHSDFETWH-X-EDG-
M/L-P
159. This motif is invariably present in the amino acid
sequence of each of the 71 EctD-type proteins compiled by us, and
it stands out as the most conserved part of the ectoine hydroxylase
protein sub-family of the non-heme iron(II)-containing and 2-
oxoglutarate-dependent dioxygenases (Figure S1). The EctD
signature sequence motif comprises two (His-146 and Asp-148)
of the three residues forming the iron-binding pocket in the EctD
enzyme (Figure 4) and one of the residues (Phe-143) that in all
likelihood is involved in 2-oxoglutarate binding (Figure 5D).
It is now possible to inspect the F
143-X-WHSDFETWH-X-
EDG-M/L-P
159 motif within the framework of a crystal structure
of a biochemically characterized ectoine hydroxylase. Most of the
residues forming the ectoine hydroxylase signature-sequence motif
are structurally organized as an a-helix (a-helix 5; Figure 3D and
Figure 6). This helix consists of nine amino acids (Asp-148 to Asp-
156), all of which, except Val-154, are strictly conserved in EctD-
type proteins (Figure S1). This is in contrast to the other five a-
helices present in the EctD structure (Figure 3D), none of which
contains a single invariant amino acid (Figure S1). Along with the
carboxy-terminal loop of EctD and b-strands 3 and 4, a-helix 5
expands the ligand-binding cavity, whose core is formed by the
DSBH motif (Figure 2A and Figure 6). In analogy to what is
observed in crystal structures of EctD-related non-heme iron(II)-
containing and 2-oxoglutarate-dependent dioxygenases with
bound substrates, this expansion is likely to form an important
part of the ectoine-binding site. This assumption is strengthened
when one considers the spatial proximity within the EctD structure
of a-helix 5 to residues Val-194 and Gly-212, two residues that
flank the putative ‘‘lid’’ region of the EctD enzyme.
Despite intensive efforts, we have not been able to obtain EctD
crystals with either the substrate ectoine or the product 5-
hydroxyectoine. We can thus currently not tell how or where the
ectoine ligand is bound within the presumed EctD active site.
Figure 6. The ectoine hydroxylase signature sequence motif
represented in the context of the EctD crystal structure. The V.
salexigens EctD structure is shown in ribbon representation with those
residues constituting the EctD signature motif [F
143-X-WHSDFETWH-X-
EDG-M/L-P
159] highlighted in yellow. This string of amino acids is
invariantly present in 71 compiled EctD-type proteins (Figure S1). The
side chains of the Fe
2+-chelating amino acids (His-146, Asp-148, His-248)
are shown as red sticks and those forming the putative 2-oxoglutarate-
binding site (Phe-143, Ser-250, Arg-259) are represented by green sticks.
The iron ligand (Fe
3+) present in the EctD crystal structure is
represented as blue sphere.
doi:10.1371/journal.pone.0010647.g006
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ligand-binding proteins from an ABC and two TRAP transporters
have been reported. The binding of both compatible solutes by
EhuB from Sinorhizobium meliloti [51], TeaA from Halomonas elongata
[52], and UehA from Silicibacter pomeroyi [53] relies on cation-p
interactions between the positive charge of both ectoine and 5-
hydroxyectoine (Figure 1) and aromatic side chains of the ligand-
binding proteins and on directed protein-ligand interactions via
salt-bridges and hydrogen bonds. In view of this information, we
inspected the likely active centre of the EctD enzyme (Figure 2B
and Figure 6) for an arrangement of amino acid side chains similar
to that found within the ectoine/5-hydroxyectoine-binding pockets
of EhuB, TeaA and UehA. However, the presumed active site of
the EctD enzyme apparently does not contain an ectoine/5-
hydroxyectoine-binding site that closely matches that is present in
these ligand-binding proteins.
EctD-type proteins within the context of microbial
genomes and microbial physiology
The structural gene (ectD) for the ectoine hydroxylase is either
part of the ectoine biosynthetic gene cluster or it is encoded
separately from ectABC operon somewhere else in microbial
genomes [5,15]. Using the amino acid sequence of the ectoine
synthase (EctC) as a diagnostic tool to identify potential ectoine
producers via data-base searches, we identified 197 microbial
species as putative ectoine producers. Of these, 67 species were
also found to contain EctD-type ectoine hydroxylases. Four
microbial genomes carried two copies of ectD genes.
The 71 compiled EctD-type proteins exhibit a degree of amino
acid sequence identity to the EctD protein from V. salexigens that
ranges from 55 to 41%. These proteins comprise a similar number
of amino acid residues and all align with each other without major
gaps (Figure S1). Only a sub-group of these EctD-type proteins are
currently functionally annotated in the databases as ectoine
hydroxylases. Many EctD-type proteins are referred to as either
proline- or phytanoyl-CoA-hydroxylases, or are non-specifically
referred to as probable hydroxylases/dioxygenases. Proline-
hydroxylases are members of the non-heme iron(II)-containing
and 2-oxoglutarate-dependent dioxygenase superfamily (EC
1.14.11) and carry out an enzymatic reaction similar to that
catalyzed by the EctD ectoine hydroxylase [54,55], but the amino
acid sequence of this type of enzymes can readily be distinguished
from those of ectoine hydroxylases in BLAST searches. Our
finding that EctD is structurally closely related to the human
phytanoyl-CoA-hydroxylase PhyH (Figure 3A), probably explains
the annotation of many EctD-type hydroxylases in the databases
as putative microbial phytanoyl-CoA-hydroxylases.
Microbial genomes usually contain only one copy of the ectD
gene but we found four exceptions: Rhodococcus sp. RHA1,
Rhodococcus opacus B4, Marinobacter aquaeolei VT8 and C. salexigens
each encode two EctD-type proteins (Figure S1). In the case of C.
salexigens, the contributions of the two EctD-type proteins (referred
to as EctD and EctE, respectively) for the synthesis of 5-
hydroxyectoine have already been investigated through gene
disruption experiments. Only the EctD protein significantly
contributes to 5-hydroxyectoine production, despite the fact that
the amino acid sequence of EctD and EctE of C. salexigens are 50%
identical [16].
Ectoine and 5-hydroxyectoine were so far considered as
compatible solutes exclusively synthesised by members of the
domain of the Bacteria [4]. However, our database searches
revealed an EctD-type protein encoded in the genome of the
archaeon Nitrosopumilus maritimus SCM1 (NCBI accession number
NC_010085). The ectD gene of this marine group 1 Crenarchaeon
[56] is part of a gene cluster (ectABCD) that encodes the three
enzymes required for ectoine biosynthesis as well. There is
considerable evidence for extensive lateral gene transfer between
members of the domains of the Bacteria and the Archaea [57,58]. It
is thus tempting to speculate that N. maritimus SCM1 acquired the
ectoine and 5-hydroxyectoine biosynthetic genes via lateral gene-
transfer from a member of the Bacteria that shares the marine
habitat with this archaeon. The presence of the ectoine/5-
hydroxyectoine gene cluster in N. maritimus SCM1 was recently also
noted by Lo et al. [15] in connection with a cohesion group
approach for the evolutionary analysis of microbial aspartokinases,
enzymes that are crucial for the production of L-aspartate-b-
semialdehyde, the precursor for the biosynthesis of ectoine [15,59].
EctD-possessing microorganisms are quite diverse with respect
to their taxonomic affiliation, physiology, lifestyles and habitats
(Figure S1). There are well-known pathogens among this group of
bacteria such as Norcadia farcina, Mycobacterium abscessus and various
species of Bordetella. But there are also representatives of
biotechnologically important microorganisms such as S. coelicolor
and Streptomyces griseus, which are both employed for antibiotic
production. Represented are also microorganisms that live in
extreme habitats with respect to growth temperature (e.g. the
thermophilic Geobacillus sp Y412MC10 and the psychrophilic
Sphingopyxis alaskensis RB2256) and pH tolerance (e.g. Acidiphilum
cryptum JF5 and Alkalilimnicola ehrlichei MLHE-1). A substantial
number of ectD-possessing microorganisms inhabit high-salinity
environments or marine habitats. One representative of this group
is the cosmopolitan hydrocarbonoclastic marine bacterium
Alcanivorax borkumensis SK2, whose ability to synthesize ectoine
and 5-hydroxyectoine is key for its ability to colonize high salinity-
habitats [60]. It will be interesting to see in future studies how the
EctD-mediated synthesis of 5-hydroxyectoine contributes to the
specific adaptation of microorganisms to their varied ecological
niches.
Materials and Methods
Chemicals
Ectoine and 5-hydroxyectoine either were purchased from
Biomol (Hamburg, Germany) or were a kind gift from Dr. T.
Schwarz (Bitop AG, Witten, Germany). 2-oxoglutarate (disodium
salt) was obtained from Sigma-Aldrich (St. Louis, MO, USA).
Anhydrotetracycline-hydrochloride, desthiobiotin, and Strep-Tac-
tin Superflow chromatography material were purchased from IBA
(Go ¨ttingen, Germany).
Culture conditions for bacterial strains
E. coli strains were grown aerobically in Luria-Bertani (LB) rich
medium and were propagated on LB-agar plates at 37uC [61].
Ampicillin (100 mgm L
21) was added to liquid and solid media to
select for the presence of the ectD
+ plasmid pBJ10 [5] in the E. coli
strain DH5a (Invitrogen, Karlsruhe, Germany). Overproduction
of the EctD protein was performed in minimal medium A [61]
with 0,5% (w/v) glucose as the carbon source, 0.5% (w/v)
casaminoacids, 1 mmol L
21 MgSO4 and 3 mmol L
21 thiamine.
Overproduction and purification of the recombinant
EctD protein in E. coli
Plasmid pJB10 is a derivative of the expression vector pASK-
IBA3 (IBA, Go ¨ttingen, Germany) and carries the ectD
+ gene from
V. salexigens (DSM 11483
T) under the transcriptional control of the
anhydrotetracycline-inducible tet-promotor present on pASK-
IBA3. The ectD coding region is fused at its 39-end to a DNA
segment that encodes a Step-tag-II affinity peptide. Expression of
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triggered by the addition of anhydrotetracyline (final concentra-
tion: 0.2 mgm L
21) to mid-log-phase-cultures (OD578 of 0.7)
propagated in minimal medium A. Growth of the cells was
continued for two hours after the addition of the inducer to allow
EctD-Strep-tag-II protein production, and the cells were subse-
quently harvested by centrifugation (4uC, 10 min at 5 0006g).
EctD-Strep-tag-II production was carried out in batch-cultures
(661 liter minimal medium A). The recombinant EctD-Strep-tag-II
protein was purified from cleared cell lysates of the E. coli DH5a
(pJB10) producer cells by affinity chromatography on a Strep-
Tactin Superflow column as detailed by Bursy et al. [5]. In general,
approximately 8 mg of purified EctD-Strep-tag-II protein were
obtained per liter of E. coli DH5a (pJB10) culture. The purified
EctD-Strep-tag-II protein was shock-frozen in liquid nitrogen and
stored at 280uC for subsequent enzyme assays [5] and
crystallization trials.
Crystallization of the EctD protein from V. salexigens
The EctD-Strep-tag-II protein was crystallized at 293 K by the
hanging-drop vapour diffusion method using VDX
TM plates
(Hampton Research, USA). For an initial screen, the 98 solutions
of the Crystal Screen and Crystal Screen II kit from Hampton
Research (USA) were used. 1.5 mL of protein solution (10 g L
21
E c t Dp r o t e i ni n1 0m m o lL
21 TES, pH 7.5; 80 mmol L
21 NaCl;
2m m o lL
21 DTT) were mixed with 1.5 mL reservoir solution and
equilibrated against 0.5 mL of reservoir solution. A large number of
very small crystals appeared overnight in 2.0 mol L
21 (NH4)2SO4
buffered with 0.1 mol L
21 sodium acetate (pH 4.6); Crystal Screen
#47). Optimization of this condition using the Additive Screen
kit from Hampton Research (USA) led to a reservoir solution
containing 1.0 mol L
21 (NH4)2SO4,0 . 1m o lL
21 NaF, 2 mmol L
21
TCEP, 0.02% (w/v) sodium azide buffered with 0.1 mol L
21 sodium
acetate at pH 5.0. When 2 mL of protein solution were mixed with
3 mL of the refined reservoir solution, large crystals were obtained
a f t e rf i v ed a y s .T h ec r y s t a l sw e r eo fb i p y r a m i d a ls h a p ew i t ha
hexagonal base and were approximately 0.8 mm in length and
0.5 mm in width. Only a small fraction of the obtained crystals
showed good diffraction behaviour. Omitting NaF from the reservoir
solution inevitably resulted in morphologically imperfect crystals
exhibiting an extremely high mosaicity. For a multiwavelength
anomalous diffraction (MAD) experiment, selenomethionine (Se-
Met)-substituted EctD was produced according to the metabolic
inhibition protocol established by Van Duyne et al. [62] with slight
modifications. The presence of the SeMet in the protein was
confirmed by matrix-assisted laser desorption/ionisation (MALDI-
TOF) mass spectrometry. Purification was identical to sulfurmethio-
nine EctD. For crystallization of SeMet-labelled EctD the concen-
tration of (NH4)2SO4 in the reservoir solution had to be decreased
to 0.9 mol L
21.
Data collection, processing, and structure determination
by means of multiwavelength anomalous diffraction
(MAD)
For data collection at 100 K, crystals were cryopreserved in a
reservoir solution with an increased (NH4)2SO4 concentration
(1.4 mol L
21) plus 30% (v/v) glycerol. The crystals belonged to the
hexagonal space group P6522 with unit cell dimensions of
a=b=102.7 A ˚, c=158.8 A ˚. Calculation of a Matthews coefficient
of 3.7 A ˚ 3/Da implied one protein monomer per asymmetric unit,
yielding a solvent content of 66.9%. The crystal structure of EctD
was determined by MAD using selenium of SeMet incorporated
into the EctD protein as anomalous scatterer [63]. The MAD
experiment was performed at the Proteine Structure Factory (PSF)
beamline 14.2 at the Berliner Elektronenring-Speicherring fu ¨r
Synchrotronstrahlung (BESSY; Berlin, Germany) equipped with a
MAR-165CCD detector. One crystal of selenomethionyl EctD
was used to collect a MAD data set at three different wavelengths
at 2.1 A ˚ resolution each (1u oscillation steps at a crystal to detector
distance of 150 mm). Subsequently, data of 1.85 A ˚ resolution were
collected from a further crystal of selenomethionyl EctD (0.5u
oscillation steps at a crystal to detector distance of 135 mm) at the
remote wavelength. This data set was used as the ‘‘native’’ data set
and for refinement of the EctD crystal structure. All data were
processed and scaled with the programs DENZO and SCALE-
PACK implemented in the HKL2000 package [64]. For MAD
data the option ‘NO MERGE ORIGINAL INDEX’ was used to
allow local scaling. Data collection statistics are summarized in
Table S1. The data quality was examined with SHELXC as
implemented in HKL2MAP [65]. The ‘‘native’’ data set was used
as a reference for the calculation of the correlation coefficient. The
anomalous signal/noise (.1.5) and the correlation coefficient
(.30) between data sets were significant up to a resolution of
2.2 A ˚. The selenium substructure was determined with the
program SHELXD [66]. Five of the seven selenium atoms
present in the SeMet-labelled EctD protein were found. Among
these was the selenium atom of the N-terminal methionine of
EctD, which was only poorly defined both in the experimental
and refined electron density map. In addition, a complexed Fe
3+
ion showing a week anomalous signal at the wavelengths used for
the MAD experiment was identified. The correlation coefficient
for the best solution was 71.0 and the R-factor was 21.1%.
Reference phases from the selenium positions were calculated
and improved by density modification using SHELXE [67].
Phase extension was performed with the ‘‘native’’ dataset to
1.85 A ˚ resolution. The correct enantiomorph of the Patterson
function returned a single solution with a final contrast of 1.00
and a connectivity of 0.95 (inverted site ; P6122: contrast: 0.07,
connectivity: 0.73).
Model building and crystallographic refinement
The automatic model building program ARP/wARP was
applied for automatic tracing of the electron density and model
building [68]. After 200 refinement cycles, this procedure provided
an initial model consisting of 276 out of 300 amino acid residues
(not taking into account the carboxy-terminal Strep-affinity tag)
with a connectivity index of 0.99. Residues 195 to 212 as well as
the six C-terminal residues 295 to 300 were missing in this first
model. A Fe
3+ ion that was clearly visible in the experimental
electron density was manually introduced. Initially, simulated
annealing and B-factor refinement was performed in CNS [69].
After some cycles of refinement, the refined electron density
allowed building of residues 212, 295 and 296 using the program
O [70]. In addition, the refined electron density clearly revealed
two alternative side chain conformations for residues SeMet-63,
Ser-73, Asp-101, Asp-124 and Ile-229. The alternative side chain
conformations, two glycerol molecules and four sulfate ions that
were visible in the electron density, were built in O. Further
refinement of the model was done using the program SHELXL
[71] until the Rfree no longer decreased (see Table S2 for
refinement and model statistics). Since no or only poor electron
density could be assigned to the side chains of Glu-2, Leu-4, Gln-9,
Asn-10, Asn-11, Gln-12, Lys-14, Lys-17, Glu-38, Glu-85, Glu-87,
Lys-141, Phe-143, Lys-292, Gln-293 and Val-295, these residues
were modelled as alanines. The Q,y-angle combination of Glu-87
whose main chain portion was excellently defined in the electron
density map is in the forbidden area of the Ramachandran plot. As
Ectoine Hydroxylase
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in a type IV beta turn motif.
Protein Data Bank accession number
The coordinates of the EctD crystal structure in complex with
Fe
3+ were deposited with the Brookhaven Protein Data Bank
under accession number 3EMR.
Figure preparation
Structural figures were prepared using Pymol (http://www.
pymol.org).
Database searches and computer analysis of protein
sequences
Proteins that are homologous either to the EctC or EctD
proteins from V. salexigens were searched via the Web-server of the
DOI Joint Genome Institute (http://www.jgi.doe.gov/) or that of
the National Center for Biotechnology Information institute
(http://www.ncbi.nlm.nih.gov/) using the Blast algorithm [73].
The genome context of finished and unfinished microbial genomes
in the vicinity of the ectD gene was analyzed using the gene
neighbourhood tool (http://img.jgi.doe.gov/cgi-bin/pub/main.
cgi) provided by the JGI Web-server. Sequence alignments of
EctD-type proteins were performed using ClustalW [74] as
implemented in the Vector NTI software package (Invitrogen,
Karlsruhe, Germany).
Supporting Information
Figure S1 The Virgibacillus salexigens EctD amino acid sequence
(accession number: AAY29689) was used as a query sequence in
BLAST searches using the web tools of the National Center for
Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.
gov/) or the Joint Genome Institute (JGI; http://www.jgi.doe.
gov/). The retrieved amino acid sequences were then aligned
using the ClustalW algorithm as implemented in the Vector NTI
DNA analysis software. The position of those amino acids that are
involved either in iron or in 2-oxoglutarate binding by the V.
salexigens EctD protein are labelled by red and green boxes,
respectively. The numbering of these residues is according to the
amino acid sequence of the V. salexigens EctD protein.
Found at: doi:10.1371/journal.pone.0010647.s001 (0.36 MB
PDF)
Table S1 X-ray data collection statistics for the EctD protein.
Found at: doi:10.1371/journal.pone.0010647.s002 (0.03 MB
DOC)
Table S2 Refinement and model statistics for the EctD crystal
structure (PDB code: 3EMR).
Found at: doi:10.1371/journal.pone.0010647.s003 (0.03 MB
DOC)
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